Works matching DE "OVERALL survival"


Results: 5000
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Durvalumab Alone or Combined With Novel Agents for Unresectable Stage III Non–Small Cell Lung Cancer: Update From the COAST Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2025, v. 8, n. 7, p. e2518440, doi. 10.1001/jamanetworkopen.2025.18440
    By:
    • Aggarwal, Charu;
    • Martinez-Marti, Alex;
    • Majem, Margarita;
    • Barlesi, Fabrice;
    • Carcereny, Enric;
    • Chu, Quincy;
    • Monnet, Isabelle;
    • Sánchez-Hernández, Alfredo;
    • Dakhil, Shaker;
    • Camidge, D. Ross;
    • Pillet, Marine;
    • Brown, Miranda;
    • Paliompeis, Christos;
    • Dowson, Adam;
    • Cooper, Zachary A.;
    • Kumar, Rakesh;
    • Herbst, Roy S.
    Publication type:
    Article
    15
    16
    17
    18

    Transarterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma: a prospective, multi-center, real-world study (Ahend-HAP02).

    Published in:
    Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1615911
    By:
    • Yuan, Hang;
    • Li, Zhen;
    • Cao, Guang-Shao;
    • Xu, Fei;
    • Wu, Gang;
    • Ding, Peng-Xu;
    • Wei, Qiu-Liang;
    • Chang, Zu-Kuan;
    • Xing, Cheng;
    • Niu, Huan-Zhang;
    • Yin, Jun;
    • Yao, Quan-Jun;
    • Zheng, Lin;
    • Xiao, Jin-Cheng;
    • Chen, Cheng-Shi;
    • Cheng, Hong-Tao;
    • Zong, Deng-Wei;
    • Xia, Wei-Li;
    • Geng, Xiang;
    • Zhao, Xiao-Hui
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Karcinom plic.

    Published in:
    Studia Pneumologica et Phthiseologica, 2025, v. 85, n. 3, p. 79
    By:
    • Skřičková, J.
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Prostate-specific Antigen Decline During Primary Androgen-deprivation Therapy for Predicting Response and Survival in Metastatic Castration-resistant Prostate Cancer Patients Receiving Enzalutamide.

    Published in:
    In Vivo, 2025, v. 39, n. 4, p. 2209, doi. 10.21873/invivo.14016
    By:
    • YUJIRO NAGATA;
    • TAKAOMI SUGI;
    • SOHEI YAMAMURA;
    • YOSHIHIRO SUGITA;
    • YUI MIZUSHIMA;
    • TAKUO MATSUKAWA;
    • TOMOHISA TAKABA;
    • KAZUMASA JOJIMA;
    • KATSUYOSHI HIGASHIJIMA;
    • MASAHIRO MATSUMOTO;
    • AKINORI MINATO;
    • IKKO TOMISAKI;
    • EIJI KASHIWAGI;
    • NAOHIRO FUJIMOTO
    Publication type:
    Article
    43

    The Usefulness of the Modified Advanced Lung Cancer Inflammation Index (mALI) as a Prognostic Factor in Patients With Esophageal Cancer who Have Undergone Curative Resection.

    Published in:
    In Vivo, 2025, v. 39, n. 4, p. 2176, doi. 10.21873/invivo.14013
    By:
    • SOSUKE YAMAMOTO;
    • TORU AOYAMA;
    • YUKIO MAEZAWA;
    • ITARU HASHIMOTO;
    • RYUKI ESASHI;
    • KAZUKI OTANI;
    • SUGURU NUKADA;
    • TETSUSHI ISHIGURO;
    • KIYOKO SHIMADA;
    • KEISUKE KAZAMA;
    • KOJI NUMATA;
    • MAMORU UCHIYAMA;
    • REI HATAYAMA;
    • AYAKO TAMAGAWA;
    • AYA SAITO;
    • NORIO YUKAWA
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50